That is what supervised peptide therapy looks like compared to sourcing and self-administering without clinical oversight
(You may still be eligible if you are also enrolled in a standalone Part D plan.) You have a diagnosis of type 2 diabetes or metabolic dysfunction associated steatohepatitis (MASH)
Each box has a specific design and color scheme to make it easily identifiable
SURMOUNT-1 Trial (Mounjaro) The SURMOUNT-1 trial demonstrated that tirzepatide at doses of 5mg, 10mg, and 15mg produced average weight loss of 15%, 19.5%, and 20.9%, respectively, over 72 weeks, compared to 3.1% with placebo
Following a structured tirzepatide meal plan that prioritizes protein, fiber, and micronutrient density ensures you lose fat rather than muscle
With the right medication, lifestyle modifications, and ongoing medical support, individuals with type 2 diabetes can achieve better glycemic control and improve their overall health and well-being